Additional License. Certain Software may be delivered with its own specific license (“Additional License”). In such a case, the terms of the Additional License will be delivered to State Purchaser, such as in a separate license .txt file or as part of a separate click-to-accept agreement, and will govern use of the Software by State Purchaser to the extent Contractor does not have a right to supersede them. Contractor’s licensors are third party beneficiaries of these license provisions (and those in the Master Agreement) with respect to their software and documentation.
Additional License. Upon the SGI Group's request, MIPS shall license to the SGI Group under commercially favorable terms, any MIPS Improvements or other MIPS technology or designs it makes available to its customers or third parties, not already licensed hereunder. MIPS shall deliver all such technology when MIPS makes such it generally available to MIPS customers and licensees or upon SGI's reasonable written request provided that SGI may make such request no more once in any six (6) month period. MIPS shall deliver the applicable changes to software source code and any reasonably available supporting documentation.
Additional License. To the extent Bayer wishes to obtain (a) a commercial license under any Know How or Patent Rights Controlled by Atara that is [[***]], or (b) [[***]] under Section 2.1.2, Bayer may, during the term of this Agreement, notify Atara of its desire to enter into negotiations regarding such potential license or expansion by providing written notice to Atara specifying (i) [[***]] or (ii) [[***]] license under the Know How granted to Bayer and its Affiliates under Section 2.1.2, as applicable. Upon Atara’s receipt of any such notice and if Atara so agrees in its sole discretion, the Parties shall discuss the terms of a possible license agreement with respect to the relevant intellectual property rights for which Bayer has requested a license.
Additional License. Employees required to be licensed and/or certified in more than one (1) legal jurisdiction because of job requirements will have the additional license and/or certification paid for by the Employer.
Additional License. During the term of the paid License, the Licensee has the right to request the granting of the right to use the Service for additional users ("Additional License"). The amount of the additional license fee is set by the Price List valid at the time of granting the Additional License, unless otherwise agreed by the Parties. When calculating the license fee, an incomplete month of granting the License is taken as a full month. An additional license is granted to the Licensee subject to payment of an additional license fee within the terms and in the amount agreed by the Parties. If at the time of the request for an Additional License, the Licensee has a debt in paying the license fee, the Licensor has the right not to grant the Additional License to the Licensee until the Licensee fully repays the debt and pays the additional license fee.
Additional License. Inovio hereby agrees to expand the license granted to Advaccine under Section 2.1 for Advaccine, by itself or through any of its Affiliates or a Third Party, to conduct the Phase 3 Clinical Trial in the Inovio Territory at Advaccine’s own cost and expense for the purpose of obtaining the Regulatory Approval of the Product in the Advaccine Territory, in the event of (i) unless a Phase 3 Clinical Trial in the Inovio Territory has already been completed, a Change of Control of Inovio, where the acquirer of Inovio, by itself or through any of its Affiliates or a Third Party, is developing, manufacturing or commercializing any Competing Product for the Advaccine Territory; (ii) an official request by any Regulatory Authority in the Advaccine Territory; (iii) the occurrence of such circumstances as described in Section 4.2; or (iv) otherwise upon mutual agreement of the Parties; provided, however, that Inovio shall have the right to review and approve the protocols and design of such Phase 3 Clinical Trial. Inovio hereby agrees to expand the license granted to Advaccine under Section 2.1 for Advaccine to have the Inovio Device Manufactured in the U.S. or any other mutually agreed upon country by a Third Party contract manufacturer for use with the Product in the Advaccine Territory in the event of the occurrence of an Insolvency Event of Inovio.
Additional License. Once the training has been completed, the Marketing Partner shall have the additional right and license to use the Software for the purpose of providing support to End Users as set forth herein.
Additional License. RIGHTS In addition to the Products listed above, HSNS may license to End Users and Authorized Sublicensees, in accordance with the terms and conditions of this Agreement, the right to create a product utilizing the DLL which product cannot have any more functionality or uses or applications than any single Product of the Products listed above in Part 1, pursuant to a License Agreement or Sublicensee Agreement, each of which must be agreed to in advance in writing by LTD. Although the DLL is not a Product, the foregoing additional license rights shall be included in the definition of Product hereunder. 24 <PAGE> 25 EXHIBIT B DOCUMENTATION The Documentation for the Streaming Product, Video Mail Product (Release 1.0) and 4U2C Product is attached hereto. 25 <PAGE> 26 EXHIBIT C FORM OF LICENSE AGREEMENT The attached form of License Agreement contains the required terms for the License Agreement. 26 <PAGE> 27 EXHIBIT D THIRD PARTY MATERIALS See Exhibit B. The Documentation for each Product as listed in Exhibit B lists any Third Party Materials for such Product. 27 <PAGE> 28 EXHIBIT E Existing Licensing/Marketing Agreements: To the best of LTD's knowledge, after due diligence and investigation, the existing licensing/marketing agreements are as attached hereto. HSNS shall cooperate with LTD, and permit LTD to amend this Exhibit, to the extent that additional existing licensing/marketing agreements are identified after the date hereof which do not unreasonably interfere with HSNS's rights hereunder. EXHIBIT E <TABLE> <CAPTION> AGREEMENT TYPE COMPANY NAME DATE -------------- ------------ ---- <S> <C> <C> IDV Adobe Systems, Inc. 6/15/96 MDI Adobe Systems, Inc. 9/26/97 NDA Applied Communications Concerts, Inc. 3/11/96 PDA Ball Corp. 9/7/94 CA Base-Ten Systems Inc. 9/2/94 PDA BellSouth 10/6/95 NDA Xxxx-Xxxxx & Xxxxxxxx Inc. 10/18/95 NDA Cambridge Parallel Processing Ltd. 11/5/95 CNCA Carolina First 5/14/98 NDA CBI Microsystems 7/29/97 NDA Century Business Services 3/2/98 PLA Chori America Inc. 5/15/98 SLA Clorepo Inc. 12/4/95 PLA Compaq Computer Corp. 2/21/97 Compression Systems 10/16/96 NDA CompuServe 3/15/96 SLA Computer Presentations Inc. 3/15/93 LMA Computer Presentations Inc. 12/9/94 SLA Concept Corp. 10/17/96 NDA Concurrent Computers 2/17/98 NDA Connectix Corp. 7/18/96 PDA Continuum Technology Corp. 8/17/95 PDA Conversant Systems 8/1/94 NDA Corel Corp. 1/19/96 SLA Corel Corp. 4/24/96 NDA CRYPTEK Secure Communications 3/31/98 NDA Cycore Computers 11/1/97 </TABLE>...
Additional License provided by Service Provider to Client after the date of the final Services report and as reasonably requested by Client, which license shall be for the limited purposes of allowing Client to use the foregoing in the context of furthering the performance of its own services for its applicable client and for which the Services performed hereunder were subcontracted to Service Provider (the “Additional License”). This Additional License is irrevocable (except for breach by Client of its obligations under Section 5 with respect to the Service Provider IP subject to such Additional License), not transferable, and not sublicensable (except if Service Provider receives a prior notice of the name of any such sublicensees). ]
Additional License. The Company and the Customer shall use commercially reasonable best efforts to enter into an agreement mutually agreeable thereto pursuant to which the scope of the License shall be amended to include UB-92 claims.
